UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Leukemia, 2016-07, Vol.30 (7), p.1456-1464

2016

Volltextzugriff (PDF)

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.966-971

2014

Volltextzugriff (PDF)

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Leukemia, 2015-01, Vol.29 (1), p.137-144

2015

Volltextzugriff (PDF)

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.630-641

2013

Volltextzugriff (PDF)

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320

2015

Volltextzugriff (PDF)

Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson

Leukemia, 2014-02, Vol.28 (2), p.289-292

2014

Volltextzugriff (PDF)

Effect of measurable (‘minimal’) residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia

Leukemia, 2016-10, Vol.30 (10), p.2080-2083

2016

Volltextzugriff (PDF)

New drug approvals in acute myeloid leukemia: what’s the best end point?

Leukemia, 2016-03, Vol.30 (3), p.521-525

2016

Volltextzugriff (PDF)

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

Leukemia, 2010-07, Vol.24 (7), p.1276-1282

2010

Volltextzugriff (PDF)

The quality of life of adult survivors of childhood hematopoietic cell transplant

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.746-754

2010

Volltextzugriff (PDF)

Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration

Blood cancer journal (New York), 2015-04, Vol.5 (4), p.e302-e302

2015

Volltextzugriff (PDF)

Haematopoietic cell transplantation as immunotherapy

Nature (London), 2001-05, Vol.411 (6835), p.385-389

Appelbaum, Frederick R

2001

Volltextzugriff (PDF)

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

Leukemia, 2002-09, Vol.16 (9), p.1627-1636

2002

Volltextzugriff (PDF)

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (11), p.739-748

2009

Volltextzugriff (PDF)

Prediction of CR following a second course of ‘7+3’ in patients with newly diagnosed acute myeloid leukemia not in CR after a first course

Leukemia, 2016-08, Vol.30 (8), p.1779-1780

2016

Volltextzugriff (PDF)

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Leukemia, 2010-05, Vol.24 (5), p.909-913

2010

Volltextzugriff (PDF)

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3244-3254

2001

Volltextzugriff (PDF)

Value of routine ‘day 14’ marrow exam in newly diagnosed AML

Leukemia, 2015-01, Vol.29 (1), p.247-249

2015

Volltextzugriff (PDF)

Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?

Leukemia, 2017-11, Vol.31 (11), p.2536-2537

2017

Volltextzugriff (PDF)

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report

Leukemia, 2013-01, Vol.27 (1), p.238-241

2013

Volltextzugriff (PDF)

Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony-Stimulating Factor

Blood, 1995-03, Vol.85 (6), p.1655-1658

1995

Volltextzugriff (PDF)

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Clinical pharmacology and therapeutics, 2009-06, Vol.85 (6), p.615-622

2009

Volltextzugriff (PDF)

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

The New England journal of medicine, 1997-10, Vol.337 (15), p.1021-1028

1997

Volltextzugriff (PDF)

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Blood, 1999-08, Vol.94 (3), p.1086-1099

1999

Volltextzugriff (PDF)

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Blood, 2000-02, Vol.95 (4), p.1188-1194

2000

Volltextzugriff (PDF)

1 – 25 von 1.247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.124)
Mit Volltextzugriff
(913)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.242)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(767)
Humans
(752)
Life Sciences & Biomedicine
(733)
Biological And Medical Sciences
(506)
Medical Sciences
(480)
Hematology
(445)
Female
(443)
Male
(443)
Adult
(437)
Middle Aged
(384)
Adolescent
(279)
Bone Marrow Transplantation
(270)
Oncology
(252)
Child
(212)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(180)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(179)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(177)
Aged
(173)
Transplantation
(168)
Pharmacology. Drug Treatments
(166)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(870)
MEDLINE
(850)
Publisher website
(690)
Journals@Ovid Full Text
(475)
IngentaConnect Journals
(275)
Elsevier ScienceDirect Journals Complete
(174)
Springer Nature - Connect here FIRST to enable access
(164)
Nexis Uni
(161)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(116)
Wiley-Blackwell Journals
(97)
IngentaConnect Journals
(90)
Wiley Online Library
(68)
springer (창간호~2014)
(33)
Oxford Journals Current Collection
(25)
Ebook Central Perpetual and DDA
(21)
Oxford Journals 2020 Medicine
(17)
JSTOR
(17)
eBooks on EBSCOhost
(16)
SpringerLink Series
(15)
PsycARTICLES
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(393)
Bone Marrow Transplantation
(96)
Journal Of Clinical Oncology
(59)
Leukemia
(54)
Biology Of Blood And Marrow Transplantation
(39)
Transplantation
(35)
British Journal Of Haematology
(29)
The New England Journal Of Medicine
(27)
Leukemia Research
(20)
Seminars In Hematology
(19)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson

Effect of measurable (‘minimal’) residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia

New drug approvals in acute myeloid leukemia: what’s the best end point?

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

The quality of life of adult survivors of childhood hematopoietic cell transplant

Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration

Haematopoietic cell transplantation as immunotherapy

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Prediction of CR following a second course of ‘7+3’ in patients with newly diagnosed acute myeloid leukemia not in CR after a first course

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Value of routine ‘day 14’ marrow exam in newly diagnosed AML

Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report

Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony-Stimulating Factor

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Suchergebnisse filtern